HKU Scholars Hub: Browsing DSpace

Browsing by Author Gane, EJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 10 of 10

	Title	Author(s)	Issue Date	Views
	An integrated analysis of phase 2,3 SOF and LDV/SOF trials for the treatment of GT6 HCV Infection Proceeding/Conference:Hepatology International	Lai, CL Chuang, WL Hassanein, T Kowdley, KV Lawitz, E Gao, B Mo, HM Hyland, R Yang, JC De-Oertel, S Natha, M Brainard, D Knox, SJ McHutchison, JG Chan, HLY Gane, EJ	2016	49
	eGFR Improvement In Chronic Hepatitis B Patients With Telbivudine Treatment Is Independent Of Antiviral Activity Proceeding/Conference:Journal of Hepatology	Gane, EJ Liaw, YF Wang, Y Lai, CL Rasenack, J Zeuzem, S Chan, HLY Ren, H Dong, Y Uddin, A Jung, ME Bosset, S Trylesinski, A	2013	82
	Evaluation of Estimated Glomerular Filtration Rate During Continuous 4-Year Treatment with Telbivudine in Patients with Bridging Fibrosis/Cirrhosis Proceeding/Conference:Journal of Hepatology	Gane, EJ Lai, CL Xie, Q Liaw, YF Thongsawat, S Chan, HLY Wang, Y Hwang, SG Safadi, R Jung, M Uddin, A Janssens, N Trylesinski, A	2014	1367
	Integrated analysis of controlled clinical trials evaluating efficacy and safety of sofosbuvir-based regimens in chronic hepatitis C genotype 6 (HCV GT 6) Proceeding/Conference:Journal of Hepatology	Nguyen, MH Chuang, WL Hassanein, T Kowdley, K Lai, CL Chan, HLY Feld, JJ Letterio, C Hahambis, TA Llewellyn, J De-Oertel, S Brainard, DM Lawitz, EJ Gane, EJ	2017	17
	Pharmacokinetics (PK) and PK modeling of the first-in- class HBV core inhibitor NVR 3-778 dosed once- (QD) or twice daily (BD) in healthy volunteers (HVs) and HBeAg-positive patients witn chronic HBV infection (CHBV) Proceeding/Conference:Hepatology	Kakuda, T Del Bene, E Yuen, RMF Gane, EJ Kim, S Liaw, S Brown, N Klumpp, K Flores, F Chanda, S	2016	28
	Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma Journal:Clinical Cancer Research	Lim, HY Merle, P Weiss, KH Yau, TCC Ross, P Mazzaferro, V Blanc, JF Ma, YT Yen, CJ Kocsis, J Choo, SP Sukeepaisarnjaroen, W Gérolami, R Dufour, JF Gane, EJ Ryoo, BY Peck-Radosavljevic, M Dao, T Yeo, W Lamlertthon, W Thongsawat, S Teufel, M Roth, K Reis, D Childs, BH Krissel, H Llovet, JM	2018	10
	REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) - A Risk Score for the Prediction of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis (CHB) Patients Treated with Oral Anti-HBV Therapy Proceeding/Conference:Hepatology	Nguyen, MH Yang, HI Yeh, ML Wong, GL Peng, CY Chen, CH Trinh, HN Cheung, KS Su, TH Kozuka, R Ogawa, E Li, J Zhang, JQ Wong, C Wong, Clifford Prasad, D Hoang, J Lin, CH Ueno, Y Gane, EJ Xing, H Furusyo, N Enomoto, M Kao, JH Yuen, RMF Yu, ML	2017	12
	Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: A randomized trial Journal:American Journal of Transplantation	Abdelmalek, MF Humar, A Stickel, F Andreone, P Pascher, A Barroso, E Neff, GW Ranjan, D Toselli, LT Gane, EJ Scarola, J Alberts, RG Maller, ES Lo, CM Sirolimus Liver Conversion Trial Study Group	2012	92
	Sofosbuvir and Ledipasvir/Sofosbuvir for the treatment of patients with Chronic Genotype 6 Hepatitis C Virus Infection: integrated analysis of Phase 2 and Phase 3 studies Proceeding/Conference:Hepatology	Gane, EJ Chuang, WL Hassanein, TI Kowdley, KV Lawitz, E Gao, B Mo, H Hyland, RH Yang, JC De-Oertel, S Brainard, DM Knox, SJ McHutchison, JG Lai, CL Chan, HLY	2015	178
	Telbivudine improves renal function in patients with chronic hepatitis B Journal:Gastroenterology	Gane, EJ Deray, G Liaw, YF Lim, SG Lai, CL Rasenack, J Wang, Y Papatheodoridis, G Di Bisceglie, A Buti, M Samuel, D Uddin, A Bosset, S Trylesinski, A	2014	36

Showing results 1 to 10 of 10